jueves, 23 de diciembre de 2021

ASPR pauses allocation of bamlanivimab and etesevimab together, etesevimab alone, and REGEN-COV

https://www.phe.gov/emergency/events/COVID19/therapeutics/update-23Dec2021/Pages/default.aspx?utm_medium=email&utm_source=govdelivery

No hay comentarios:

Publicar un comentario